1. Home
  2. HIT vs MCRB Comparison

HIT vs MCRB Comparison

Compare HIT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.99

Market Cap

68.8M

Sector

Finance

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$7.53

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIT
MCRB
Founded
1964
2010
Country
United States
United States
Employees
91
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
78.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
HIT
MCRB
Price
$0.99
$7.53
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$3.25
$14.00
AVG Volume (30 Days)
274.6K
33.2K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
$41.00
N/A
Revenue Next Year
$69.63
N/A
P/E Ratio
$52.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$6.56
52 Week High
$4.01
$29.98

Technical Indicators

Market Signals
Indicator
HIT
MCRB
Relative Strength Index (RSI) 35.72 42.57
Support Level N/A $7.33
Resistance Level $1.81 $9.53
Average True Range (ATR) 0.13 0.41
MACD -0.03 0.02
Stochastic Oscillator 20.37 18.17

Price Performance

Historical Comparison
HIT
MCRB

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: